Tear Trough Under-eye Filler: 3 Etiologies and the Correct Approach 2026

The vast majority of patients coming for a consultation start with the same sentence: "I want filler for the dark circles under my eyes." But when I examine the under-eye area, not every patient has the same problem. Some truly have volume loss, some have vascular transparency, and some have only pigmentation. Since all three look like "dark circles," the patient rightfully asks for filler — but if filler is applied to the wrong etiology, the result is often worse.

This guide explains which anatomical questions I ask before planning filler in the tear trough area, what I treat each etiology with, and which protocol I apply to the patient for whom I have decided on filler. This area is the least forgiving filler site on the face — there is a risk of Tyndall effect, malar edema, and even rare vascular compromise. Filler should not be applied under the eyes without the trio of correct patient selection, the right product, and the right technique.

Tear Trough Anatomy — Why Is This Area So Sensitive?

The tear trough is not composed of a single structure. It is an extremely thin transition zone where skin, muscle, ligament, and fat compartments intersect. I keep four structures in mind when planning in the field.

Tear trough ligament (TTL)

A true osteocutaneous ligament located under the orbicularis oculi muscle, extending from the maxillary bone to the skin. This ligament creates the V-shape of the under-eye hollow coming from the "inner corner." With aging, fat loss occurs on the anterior surface of the ligament, and the hollow becomes prominent. It is not really possible to "soften" the ligament except through surgical release; filler reduces the shadow by filling the depression above the ligament.

Orbicularis retaining ligament (ORL)

A ligament that starts from the lateral part of the orbital rim and attaches to the deep surface of the orbicularis muscle. It forms the outer (lateral) boundary of the tear trough. The loosening of this ligament triggers the downward migration of the fat in the lower eyelid — this creates the structure known as "festoon" and "malar bag." The presence of a festoon is a contraindication for filler.

SOOF (suborbicularis oculi fat)

The fat layer located under the orbicularis muscle, adjacent to the lower orbital rim. With age, the SOOF migrates inferiorly and undergoes atrophy; this leads to a drop in mid-face volume, deepening of the tear trough, and prominence of the nasojugal groove. SOOF augmentation can be performed with pre-periosteal filler.

Infraorbital fat (orbital fat)

Fat pads (medial, central, lateral) that remain within the septum orbitale and cushion the eyeball. With aging, the septum thins, and fat herniates — a bag appearance on the lower eyelid. In these patients, filler pushes the fat bag further forward; the solution is surgical (transconjunctival blepharoplasty).

3 Etiologies — Correct Diagnosis Leads to Correct Treatment

I keep three different causes in mind when examining the patient. These three can also coexist, but the treatment plan is shaped according to the dominant etiology.

1. Pigmentation-based (dermal melanin / post-inflammatory)

In these patients, the under-eye skin is truly darker in tone — there is post-inflammatory hyperpigmentation due to dermal melanin accumulation or chronic atopic dermatitis, allergic rhinitis, frequent eye rubbing, etc. The color does not lighten when the skin is stretched with a finger; under light, a difference in tone is visible, not a hollow.

Treatment: Topical depigmentation protocol. Cyspera (cysteamine), azelaic acid 15-20%, tretinoin 0.025-0.05% at night, SPF 50+ during the day. 3-6 months of discipline is required. Filler does not work here; on the contrary, if applied, the color darkens further with the Tyndall effect.

2. Vascular-based (thin skin, orbicularis transparency)

In these patients, the skin is very thin — the red-purple color of the orbicularis oculi muscle shows through the skin and looks like "dark circles." It is usually prominent in fair-skinned patients during periods of fatigue. The color lightens when the skin is stretched with a finger; this is the most practical differential diagnostic test.

Treatment: Protocols aimed at improving skin quality. PRP (platelet-rich plasma) sessions, dermal mesotherapy, rarely skin boosters (Restylane Vital Light, Profhilo) in thin-skinned patients. Intervention on superficial vessels with Nd:YAG or KTP laser. Filler is applied in very selected cases — only if a structural component is added; it does not work for vascular etiology alone.

3. Structural-based (volume loss + ligament tethering)

In these patients, there is a true hollow — mid-face volume loss, SOOF atrophy, loss of fullness in front of the tear trough ligament. A prominent shadow falls under side lighting, and the hollow is clearly visible when the patient is photographed from horizontal and oblique angles. When the skin is stretched, the tone is less, but the hollow remains constant.

Treatment: This is where filler belongs — only here — as a first-line treatment. True anatomical correction is achieved with the right product, right technique, and right patient selection.

Which Filler? — Only Thin, Low G-prime HA

Thick, high G-prime, projection products are not used in the tear trough area. The area is very thin, vascular, and lymphatic drainage is weak — the wrong product creates a permanent problem. My preference:

• Restylane-L — low cross-linking, fine particle, with lidocaine
• Belotero Balance — CPM technology, uniform distribution within the tissue, low Tyndall risk
• Juvederm Volbella — VYC-15L, Vycross technology, approved for periorbital
• Teosyal Redensity II — formulated specifically for under-eyes, contains amino acids + minerals

Products like Voluma, Volux, Stylage XXL, and Radiesse are not used in this area. Radiesse is considered contraindicated for the periorbital area by its manufacturer; since hyaluronidase does not work, the mistake made cannot be corrected.

Technique — Cannula, Lateral Entry, Pre-periosteal Plan

Cannula preference

I use a 22G or 25G blunt-tip cannula instead of a needle. The cannula significantly reduces the risk of vascular compromise — this is critical considering the proximity of the supratrochlear and angular arteries. I open the entry port in a lateral position on the malar eminence with a 27G needle; I advance the cannula from there medially towards the tear trough.

Plan: pre-periosteal

The filler is placed on the bone — just above the periosteum. Subdermal or intra-dermal placement is a direct invitation to the Tyndall effect. I advance the tip of the cannula at a depth where I can feel it (by making bone contact) and deposit it slowly as micro-aliquots (0.05 mL per depot).

Dose — being conservative is a must

Maximum 0.5-0.7 mL per side. A total of 1.0-1.4 mL for both sides in a single session. In this area, the "let's add a little more" approach usually results in malar edema. Stay conservative; plan a touch-up session 4-6 weeks later. The goal of the first session should be 70-80% of the correction; add the rest after the edema has settled.

Nerve avoidance

Mark the supraorbital and infraorbital nerve foramina by palpation. The infraorbital foramen is approximately at the pupil level, 8-10 mm below the infraorbital rim. Do not pass the cannula directly through this point; go around it.

Complications — The Most Common in This Area

1. Tyndall effect

A blue-gray color caused by the scattering of light by HA placed too close to the skin. Once it occurs, it can look frighteningly prominent and permanent. Treatment: hyaluronidase injection (150-300 IU local), resolves in 24-72 hours. Prevention: plan on the bone, use of cannula, selection of fine-particle product.

2. Malar edema

Lymphatic drainage of the tear trough area is weak. Incorrect location (especially above the ligament, not below) or excessive volume blocks lymphatic flow, leading to persistent edema lasting months. The patient comes in complaining of fullness in the lower eyelid every morning upon waking. Treatment: hyaluronidase, lymphatic drainage massage, antihistamine. In some cases, it can last 6-12 months; during this process, the patient constantly looks "puffy."

3. Vascular compromise (rare but serious)

The supratrochlear and angular arteries anastomose with the dorsal nasal artery; this system connects to the ophthalmic artery. Intra-arterial injection in this chain can lead to retinal artery occlusion and blindness. Cases of blindness after under-eye filler exist in the literature, though few. Use of cannula + slow injection + aspiration test + limiting the product amount to 0.05 mL per depot minimizes this risk. 1500 IU hyaluronidase is always ready in the clinic; an emergency ophthalmology consultation protocol is defined in case of serious vascular suspicion.

4. Asymmetry and nodulation

Start conservative, evaluate after 4-6 weeks. If a hardened nodule is palpated, dissolve it with hyaluronidase and re-plan. The principle of "less but right" is more important than anything else in this area.

Who Is Not a Candidate for Tear Trough Filler?

Patient selection is 60% of the treatment in this area. Filler is contraindicated in the following situations:

• Presence of festoon (saggy lower eyelid pouch): Filler enlarges the festoon. Surgery (blepharoplasty) is required.
• Malar bag (saggy bag in the zygomatic area): Lymphatic drainage is already impaired. Filler worsens the situation.
• Severe dermatochalasis (upper lid skin excess + lower lid laxity): Surgical blepharoplasty is the primary treatment.
• Significant orbital fat herniation: Filler pushes the fat bag forward; transconjunctival blepharoplasty is required.
• Active dermatological disease (eczema, atopic dermatitis flare-up): Skin is stabilized first.
• Dominant pigmentation etiology: Topical protocol first, evaluated later if necessary.
• Severe skin thinning due to advanced age: Tyndall risk is very high; filler is not recommended without improving skin quality.

Combination Protocols

Tear trough is rarely solved alone. I make a combined plan for most patients:

• PRP under-eye (3 sessions, 4 weeks apart): Improves skin quality, thickens thin skin, regulates capillary circulation. First-line in patients with a dominant vascular component.
• Mesotherapy (like NCTF 135HA, Filorga): Increases dermal hydration, supports skin brightness.
• Topical protocol: Cyspera, tretinoin, azelaic acid — addresses the pigmentation component.
• Skin booster (Restylane Vital Light, Profhilo): Vital bio-stimulant; increases skin quality and elasticity.
• Blepharoplasty consultation: Multidisciplinary with an ophthalmoplastic or plastic surgeon if structural surgery is required.

Expectation of Results — Realistic Timeline

• Immediately (day 0): Mild swelling, mild redness. Result is not fully visible.
• 3-5 days: Edema begins to settle, true contour becomes clear.
• 2 weeks: 80-90% of the result is visible.
• 4-6 weeks: Final evaluation; plan touch-up if necessary on this date.
• Longevity: Between 9-15 months depending on the product and metabolism.

Cost & Plan

Since specific pricing is not provided, for clarity: under-eye filler is planned with 1.0-1.4 mL of hyaluronic acid in a single session. PRP, mesotherapy, or skin boosters can be added to the combination protocol; in this case, package pricing varies. We provide examination + etiology differentiation + written plan during the consultation. If pigmentation or vascular etiology is dominant, I do not recommend filler; I plan an alternative protocol.

Frequently Asked Questions

1. How many months does under-eye filler last?

Usually between 9-15 months. Restylane-L and Belotero Balance last on average 9-12 months, Volbella and Teosyal Redensity II around 12-15 months. It varies according to metabolism, skin type, and daily sun exposure.

2. What is the Tyndall effect, can it be reversed?

It is a blue-gray color change caused by the scattering of light by HA placed too close to the skin. Yes, it can be reversed: it resolves in 24-72 hours with local hyaluronidase injection (150-300 IU). If new filler is to be applied, one must wait 2-4 weeks.

3. Who is not suitable for under-eye filler?

Patients with festoon, malar bag, severe dermatochalasis, significant orbital fat herniation; those with active dermatological disease; patients with dominant pigmentation or vascular etiology. In these cases, filler worsens the result.

4. How long does post-procedure edema last?

In the normal course, between 3-7 days, it usually decreases significantly within 5 days. Seeing more puffiness when waking up in the morning can last 2-3 weeks, then it normalizes. If edema still persists after 4 weeks, it may be malar edema; hyaluronidase evaluation is performed.

5. Can I have it reversed if I am not satisfied with the result?

Yes, HA filler can be reversed with hyaluronidase. It dissolves completely in 1-2 sessions. For this reason, I only use HA products in this area; Radiesse or permanent fillers are not applied to the tear trough.

6. Is there pain during the procedure?

Topical lidocaine cream is applied 30 minutes before. A mini-puncture is made with a 27G needle for cannula entry; this gives a short-term stinging sensation. Afterwards, since the product contains lidocaine, pain is minimal — 1-2/10 scale.

7. Is a combination protocol necessary, isn't just filler enough?

In a young patient with a clear structural etiology and good skin quality, filler alone may be sufficient. In most patients, skin quality also needs support; we combine it with PRP or mesotherapy. If pigmentation accompanies it, a topical protocol is a must.

8. Can it be done together with laser?

Yes, but not in the same session. First, filler is applied, wait 4-6 weeks, then skin quality is supported with non-ablative laser (Nd:YAG, fractional). In the reverse order, laser heat can disrupt the integrity of the filler.

9. Is the "tight" feeling after the procedure normal?

Slight tightness and fullness feeling in the first few days is normal — the tissue is adapting to the product. This feeling decreases within 1 week. If there is still significant tightness after 2 weeks, the volume may be high; come for a check-up to evaluate.

10. What should I pay attention to after the procedure?

Sleeping face down, heavy sports, sauna, Turkish bath, and alcohol are not recommended for the first 24 hours. Avoid intense massage, high-heat environments, and aggressive skin care (tretinoin, AHA peeling) for the first 1 week. SPF 50+ daily is a must. It is important to come for a control session after 4 weeks; necessary touch-ups are planned on this date.

Contact

The under-eye area is a field that requires examination — a treatment plan cannot be given without distinguishing the etiology. In our clinic, we perform a skin-stretching test, side-lighting examination, and digital evaluation with photos during the consultation. An alternative protocol is planned for patients who are not candidates for filler. Whatsapp: 905 323 44 82 16.

This article is for information sharing purposes. Individual treatment planning is always done after a face-to-face consultation. Medical decision-making is taken after a one-on-one meeting with the physician.